文献速递临床试验与 GCP

使用不同血压监测策略指导高血压管理(GYMNs研究):三种不同血压测量方法的比较:一项随机对照试验的研究方案

Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies (GYMNs study): comparison of three different blood pressure measurement methods: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-05-10

本研究为前瞻性双盲随机对照试验,拟招募20-90岁未控制或新诊断高血压患者,按基线收缩压130-155 mmHg和155-180 mmHg分层随机分配至家庭血压、无人值守自动血压和中心血压指导治疗三组,比较三种血压测量方法指导降压治疗的有效性和安全性,主要结局为3个月时24小时平均动态收缩压变化。

要点

  • 家庭血压、无人值守自动血压和中心血压指导治疗三组采用统一收缩压目标130 mmHg。
  • 主要结局为3个月时24小时平均动态收缩压变化,关键次要结局包括3个月达标率和12个月左心室质量下降。
  • 患者和医生通过标准化报告格式对分组设盲,每次访视均用三种方法测量血压。

核心结论

  • 据作者所知,这是首个评估高血压最佳指导策略的前瞻性双盲随机对照试验,将有助于确定哪种血压监测方法对指导高血压临床管理最有效,并为未来血压监测设备的指南推荐提供良好证据。

研究设计与样本

  • 前瞻性双盲随机对照试验,通过门诊招募20-90岁未控制或新诊断高血压患者,按基线收缩压130-155 mmHg和155-180 mmHg分层随机分配至家庭血压、无人值守自动血压和中心血压指导治疗三组。
  • 每次门诊访视时用三种方法测量血压,患者和医生通过标准化报告格式对分配干预设盲,三组采用统一收缩压目标130 mmHg。

主要发现

  • 主要结局为3个月时24小时平均动态收缩压变化。
  • 关键次要结局为3个月时达到目标血压的患者百分比和12个月时左心室质量下降。

关键数值与推荐

  • 三组收缩压目标均为130 mmHg。
  • 主要结局为3个月时24小时平均动态收缩压变化。
  • 关键次要结局包括3个月达标率和12个月左心室质量下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Home blood pressure (BP) and unattended automated BP (uAOBP) monitoring have been recommended by guidelines for the care of hypertensive subjects. However, BP measurements in the peripheral arteries cannot serve as direct substitutes for their central counterparts. Moreover, the comparative effectiveness and safety of BP-guided strategies using these BP measuring devices have never been evaluated. METHODS/DESIGN: Patients with uncontrolled or newly diagnosed hypertension aged 20-90 years will be recruited via outpatient clinics and allocated into three arms by stratified randomization (baseline systolic BP 130-155 mmHg and 155-180 mmHg): home BP, uAOBP, and central BP-guided treatment. At each scheduled visit to the clinic, a patient's BP will be measured by each of the three methods of measuring BP. The blood pressure from three different methods will be confirmed available at each visit. Patients and physicians will be blinded to the allocated interventions because they will use measured BP values in the clinic through a standardized report format. A common BP target for systolic blood pressure (SBP) of 130 mmHg is adopted for these BP-guided strategies. The primary outcome is the change of 24-h mean ambulatory SBP at 3 months. A key secondary outcome is to determine the percentage achieving their target BPs at 3 months and the decrease of left ventricular mass at 12 months. DISCUSSION: To our knowledge, this is the first prospective double-blind randomized controlled trial to assess the optimal guiding strategy for hypertension. It will help to define which BP monitoring method is the most effective for guiding the clinical management of hypertension. It will provide good evidence to support future guideline recommendations for BP monitoring devices. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03578848 . Registered on 4 June 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Cheng HM, Sung SH, Chen CH, et al. Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies (GYMNs study): comparison of three different blood pressure measurement methods: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31077229. doi:10.1186/s13063-019-3366-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。